M&A Has Been Down, But EY Argues Conditions Are Right For An Uptick In 2023

Despite concerns about the impact of the Inflation Reduction Act and constraining factors like inflation, EY believes more than $1.4tn in life sciences industry “firepower” should result in increased deal-making this year.

M&A
EY predicts an increase in M&A this year despite stricter due diligence • Source: Shutterstock

More from Strategy

More from Business